BR0312052A - Agente antialérgico, sua utilização para redução de alergia e processo de redução de alergia - Google Patents

Agente antialérgico, sua utilização para redução de alergia e processo de redução de alergia

Info

Publication number
BR0312052A
BR0312052A BR0312052-0A BR0312052A BR0312052A BR 0312052 A BR0312052 A BR 0312052A BR 0312052 A BR0312052 A BR 0312052A BR 0312052 A BR0312052 A BR 0312052A
Authority
BR
Brazil
Prior art keywords
antiallergic agent
allergy
allergy reduction
reducing
lactic acid
Prior art date
Application number
BR0312052-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Naoyuki Yamamoto
Yuu Ishida
Izuki Bando
Original Assignee
Calpis Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calpis Co Ltd filed Critical Calpis Co Ltd
Publication of BR0312052A publication Critical patent/BR0312052A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/854—Lactobacillus acidophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR0312052-0A 2002-06-26 2003-06-26 Agente antialérgico, sua utilização para redução de alergia e processo de redução de alergia BR0312052A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002185897A JP4212838B2 (ja) 2002-06-26 2002-06-26 抗アレルギー剤
PCT/JP2003/008094 WO2004002501A1 (ja) 2002-06-26 2003-06-26 抗アレルギー剤、アレルギー低減のためのその使用及びアレルギー低減方法

Publications (1)

Publication Number Publication Date
BR0312052A true BR0312052A (pt) 2005-03-29

Family

ID=29996753

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0312052-0A BR0312052A (pt) 2002-06-26 2003-06-26 Agente antialérgico, sua utilização para redução de alergia e processo de redução de alergia

Country Status (21)

Country Link
US (2) US20050214270A1 (https=)
EP (1) EP1555028B1 (https=)
JP (1) JP4212838B2 (https=)
KR (2) KR20080018287A (https=)
CN (1) CN100567489C (https=)
AT (1) ATE444074T1 (https=)
AU (1) AU2003246204B2 (https=)
BR (1) BR0312052A (https=)
CA (1) CA2490896C (https=)
DE (1) DE60329516D1 (https=)
DK (1) DK1555028T3 (https=)
ES (1) ES2331180T3 (https=)
MX (1) MXPA04012636A (https=)
NO (1) NO20050411L (https=)
PL (1) PL204931B1 (https=)
PT (1) PT1555028E (https=)
RU (1) RU2336886C2 (https=)
TW (1) TW200402304A (https=)
UA (1) UA86349C2 (https=)
WO (1) WO2004002501A1 (https=)
ZA (1) ZA200500715B (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1010487A6 (nl) 1996-06-11 1998-10-06 Unilin Beheer Bv Vloerbekleding bestaande uit harde vloerpanelen en werkwijze voor het vervaardigen van dergelijke vloerpanelen.
JP4688457B2 (ja) * 2004-09-10 2011-05-25 四国乳業株式会社 免疫増強組成物
JP4823503B2 (ja) * 2004-10-14 2011-11-24 ジェンモント バイオテック インコーポレイテッド Ｌａｃｔｏｂａｃｉｌｌｕｓｆｅｒｍｅｎｔｕｍの新規微生物株ＧＭ−０９０、およびＩＦＮ−γ分泌の刺激および／またはアレルギーの処置のためのその使用。
US7351572B2 (en) 2004-10-15 2008-04-01 Genmont Biotech Inc. Microorganism strain GM-090 of Lactobacillus fermentum and its use for stimulating IFN-γ secretion and/or treating allergy
TW200637908A (en) 2005-01-04 2006-11-01 Calpis Co Ltd Method for preparation of lactic acid bacterium having anti-allergic activity
KR101312745B1 (ko) 2005-03-03 2013-09-27 가부시키가이샤 메이지 면역기능 조정제
TW200700074A (en) * 2005-03-04 2007-01-01 Calpis Co Ltd Inducer of t cell apoptosis
ES2463724T3 (es) 2005-10-11 2014-05-29 Probiotical S.P.A. Procedimiento de preparación de cultivos bacterianos probióticos analérgicos y uso relacionado
EP1961309A4 (en) 2005-12-06 2010-01-20 Otsuka Pharma Co Ltd EMBRYONIC AXIS FERMENTATION PRODUCT OF SOYBEAN CONTAINING EQUOL, AND METHOD FOR PRODUCING THE SAME
MX2009003260A (es) * 2006-10-02 2009-05-11 Danisco Probioticos para el uso en la reduccion de la incidencia y duracion de la enfermedad.
EA016734B1 (ru) * 2006-12-21 2012-07-30 Калпис Ко., Лтд. СРЕДСТВА ДЛЯ СТИМУЛЯЦИИ ПРОДУЦИРОВАНИЯ IgA НА ОСНОВЕ БАКТЕРИЙ LACTOBACILLUS AMYLOVORUS И ШТАММ БАКТЕРИЙ LACTOBACILLUS AMYLOVORUS CP1750 FERM BP-10532
CN101796187A (zh) 2007-07-04 2010-08-04 龟甲万株式会社 乳酸菌来源的双链rna
RU2431663C2 (ru) * 2008-01-28 2011-10-20 Общество с ограниченной ответственностью "ИнноПроб" (ООО "ИнноПроб") ИММУНОБИОЛОГИЧЕСКОЕ ПРОТИВОАЛЛЕРГИЧЕСКОЕ СРЕДСТВО (ВАРИАНТЫ) И ШТАММ Lactobacillus acidophilus 100 аш ПА, ИСПОЛЬЗУЕМЫЙ ДЛЯ ПРОИЗВОДСТВА ИММУНОБИОЛОГИЧЕСКОГО ПРОТИВОАЛЛЕРГИЧЕСКОГО СРЕДСТВА
US20100055082A1 (en) * 2008-09-04 2010-03-04 Jacques Alain Bauer Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
RU2460781C2 (ru) * 2009-01-29 2012-09-10 Общество с ограниченной ответственностью "ИнноПроб" (ООО "ИнноПроб") Иммунобиологическое противоаллергическое средство (варианты), штамм lactobacillus acidophilus, используемый при приготовлении иммунобиологического противоаллергического средства
RU2393214C1 (ru) * 2009-01-29 2010-06-27 Общество с ограниченной ответственностью "ИнноПроб"(ООО"ИнноПроб") Иммунобиологическое противоаллергическое средство (варианты), штамм lactobacillus acidophilus nkjc, штамм lactobacillus acidophilus jch, штамм lactobacillus acidophilus kaa
EP2332557A1 (en) 2009-12-08 2011-06-15 Campina Nederland Holding B.V. Probiotic lactic acid bacteria
TW201300526A (zh) * 2011-03-25 2013-01-01 Calpis Co Ltd 培養基之製造方法及該方法所製造之培養基
KR101166798B1 (ko) 2011-12-19 2012-07-26 김대현 락토바실러스 애시도필러스 엘비의 사균을 포함하는 알레르기 질환의 치료 또는 예방용 의약 조성물
US9636326B2 (en) 2011-12-28 2017-05-02 Maruha Nichiro Corporation Chlorophyll c containing degranulation suppressor
JP6149228B2 (ja) * 2013-04-11 2017-06-21 アサヒグループホールディングス株式会社 免疫調節作用を有する乳酸菌のスクリーニング方法
JP5927730B2 (ja) * 2013-04-11 2016-06-01 アサヒグループホールディングス株式会社 免疫調節作用を有する乳酸菌のスクリーニング方法
KR101688224B1 (ko) * 2015-05-01 2016-12-20 일동바이오사이언스(주) 관절염 예방 및 치료 효과를 갖는 아이디-씨비티5101(id-cbt5101) 및 이의 용도
CN109195612A (zh) * 2016-05-09 2019-01-11 拜奥加亚公司 可用于过敏反应治疗的细菌菌株的选择
EP3511409A4 (en) 2016-09-12 2020-05-06 Ichibiki Co Ltd. SALT-TOLERANT LACTOBACILLA, SALT-TOLERANT LACTOBACIL CULTURE AND IMMUNOSTIMULATOR
EP3738599B1 (en) 2018-01-12 2023-12-27 GI Innovation, Inc. Composition comprising probiotics and polypeptide having binding affinity for ige and use thereof
JP2021059522A (ja) * 2019-03-20 2021-04-15 キユーピー株式会社 アレルギー症状改善用組成物
CN116035187B (zh) * 2022-12-30 2025-02-07 江南大学 一种使用植物乳杆菌发酵降低苦杏仁蛋白致敏性的方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US575270A (en) * 1897-01-12 Combined cover and stand for books
US635796A (en) * 1898-03-07 1899-10-31 Isaac Moore Manifolding sales-book.
US959766A (en) * 1909-05-14 1910-05-31 Lewis Life Wire-fastener.
US1048383A (en) * 1911-06-16 1912-12-24 Charles J Carroll Manifolding sales-book.
US1201377A (en) * 1916-07-24 1916-10-17 William S Staiars Protector-tablet.
US1915974A (en) * 1930-07-10 1933-06-27 American Sales Book Co Ltd Retaining device
US2218297A (en) * 1936-07-14 1940-10-15 Randzio Reinhold Bookkeeping system
US2806715A (en) * 1956-06-29 1957-09-17 Henry O Smith Illuminated note pad holder
JPH0634709B2 (ja) * 1985-12-03 1994-05-11 カルピス食品工業株式会社 新規乳酸菌
US4787852A (en) * 1987-04-24 1988-11-29 Melnick David W Multicolor interactive notepad
US4840406A (en) * 1987-05-29 1989-06-20 Dennison Manufacturing Company Method of mounting index tabs upon stenographic notebooks
US4816884A (en) * 1987-07-20 1989-03-28 International Business Machines Corporation High density vertical trench transistor and capacitor memory cell structure and fabrication method therefor
AU1076595A (en) * 1993-11-23 1995-06-13 Kabushiki Kaisha Wado Doctors Group Intestinal flora improver composition, and apparatus and system for producing the same
JP2992945B2 (ja) * 1994-03-11 1999-12-20 カルピス株式会社 ラクトバチルス・アシドフィルス乳酸菌
CN1110147A (zh) * 1994-04-09 1995-10-18 山田武敏 抗变态反应组合物
JPH092959A (ja) * 1995-06-16 1997-01-07 Yakult Honsha Co Ltd ＩｇＥ抗体産生抑制剤および抗アレルギー剤
JP4064480B2 (ja) * 1996-10-11 2008-03-19 ハウスウェルネスフーズ株式会社 ＩｇＧ抗体産生抑制剤
JPH10309178A (ja) * 1997-05-09 1998-11-24 Wakamoto Pharmaceut Co Ltd ビフィズス菌を有効成分とする抗アレルギー剤および醗酵食品
USD393841S (en) * 1997-05-27 1998-04-28 Fujitsu Limited Renewal of document to make alterations icon for a display screen
US6657642B1 (en) * 1997-07-03 2003-12-02 International Business Machines Corporation User interactive display interfaces with means for interactive formation of combination display objects representative of combined interactive functions
JP2000086524A (ja) * 1998-09-05 2000-03-28 Shadan Seirankai 生きた腸内細菌を含有する抗アレルギー剤
JP2000095697A (ja) * 1998-09-18 2000-04-04 Advance Co Ltd 抗アレルギー剤
JP2000239175A (ja) * 1999-02-18 2000-09-05 Calpis Co Ltd 抗アレルギー剤
US6217443B1 (en) * 1999-03-11 2001-04-17 Leonard C. Green, Jr. Carbonless paper notepad
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
AUPQ415899A0 (en) * 1999-11-19 1999-12-16 Vasse Research Institute Pty Ltd Compositions for and methods of treatment of allergic diseases
GB2365659B (en) * 2000-02-25 2002-07-24 Red Fig Ltd Serving hypermedia documents
FI110668B (fi) * 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
JP3944076B2 (ja) * 2000-08-25 2007-07-11 わかもと製薬株式会社 乳酸菌含有プロバイオティクス製品
US20030021624A1 (en) * 2001-06-29 2003-01-30 Dorsey Cheryl L. Article and method for making a notebook with permanent and disposable elements
DE20202562U1 (de) * 2002-02-19 2002-05-23 Orthomol pharmazeutische Vertriebs GmbH, 40764 Langenfeld Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika

Also Published As

Publication number Publication date
RU2005101766A (ru) 2005-08-20
KR20050014879A (ko) 2005-02-07
DE60329516D1 (de) 2009-11-12
ATE444074T1 (de) 2009-10-15
TW200402304A (en) 2004-02-16
WO2004002501A1 (ja) 2004-01-08
MXPA04012636A (es) 2005-03-23
KR20080018287A (ko) 2008-02-27
UA86349C2 (ru) 2009-04-27
EP1555028A4 (en) 2007-06-06
US20050214270A1 (en) 2005-09-29
ES2331180T3 (es) 2009-12-23
CA2490896A1 (en) 2004-01-08
PL375158A1 (en) 2005-11-28
JP4212838B2 (ja) 2009-01-21
EP1555028B1 (en) 2009-09-30
CN1678330A (zh) 2005-10-05
PL204931B1 (pl) 2010-02-26
TWI304736B (https=) 2009-01-01
KR100836727B1 (ko) 2008-06-10
EP1555028A1 (en) 2005-07-20
PT1555028E (pt) 2010-01-05
HK1081432A1 (zh) 2006-05-19
AU2003246204A1 (en) 2004-01-19
CA2490896C (en) 2011-02-01
NO20050411L (no) 2005-01-25
JP2004026729A (ja) 2004-01-29
RU2336886C2 (ru) 2008-10-27
US8003092B2 (en) 2011-08-23
AU2003246204B2 (en) 2007-07-12
CN100567489C (zh) 2009-12-09
US20090047264A1 (en) 2009-02-19
ZA200500715B (en) 2006-08-30
DK1555028T3 (da) 2010-02-01

Similar Documents

Publication Publication Date Title
BR0312052A (pt) Agente antialérgico, sua utilização para redução de alergia e processo de redução de alergia
ATE421256T1 (de) Probiotische zusammensetzung
DE60139554D1 (de) Probiotika zur primären prävention atopischer erkrankungen
WO2006084210A3 (en) Hif modulating compounds and methods of use thereof
ATE453707T1 (de) Verfahren zur isolierung von mesenchymalen stammzellen des haarfollikels
TW200740801A (en) N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase
DE50304744D1 (de) Verwendung von Riluzole kombiniert mit geeigneten Hilfs-und Zusatzstoffen zur Behandlung von Krankheiten, die durch eine Hyperproliferation von Keratinozyten gekennzeichnet sind, insbesondere Neurodermitis und Psoriasis
WO2004085628A8 (en) Lactic acid utilising bacteria and their therapeutic use
DE60211891D1 (de) Carbonsäure-substituierte oxazol-derivate zur verwendung als ppar-alpha und -gamma aktivatoren zur behandlung von diabetes
WO2007098142A3 (en) Oxazole ketones as modulators of fatty acid amide hydrolase
IS7535A (is) Lyfjablanda
MXPA05004384A (es) Piperacinil y diacepanil benzamidas y benztioamidas.
ATE535231T1 (de) Verfahren zur herstellung von poly-iclc und seine verwendung
ATE336996T1 (de) Verwendung von flavonoid-derivaten zur behandlung von atopischem ekzem
ATE396697T1 (de) Zuckerlacton enthaltende zusammensetzung zur haarbehandlung
DE602004022689D1 (de) Verwendung probiotischer bakterien zur behandlung von infektionen
WO2004108208A3 (en) Methods and apparatus for conversion of eukaryotic cells by application of electric and magnetic fields
ATE508749T1 (de) Antidepressiva zur prophylaxe und therapie von zystischer fibrose
DE60335892D1 (de) Pharmazeutische zusammensetzung zur herstellung eines medikaments zur behandlung und/oder vorbeugung und/oder fettleibigkeit im zusammenhang steht
DE60322376D1 (de) Sedative stoffe und behandlungen
ATE386513T1 (de) Verwendung von angelicin und seiner strukturellen analoga zur behandlung von thalassämie
BRPI0804965A2 (pt) método para tratar cabelo
DE502004012196D1 (de) Verwendung von isorhamnetin zur behandlung von depressiven verstimmungen und erkrankungen
EP1693063A4 (en) ANTI-ALLERICIC WITH GROUND LOTUS AND / OR LOTUS EXTRACT TOGETHER WITH MILKY ACID BACTERIUM
NO20060095L (no) Celler anvendt som baerere for bakterier

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2261 DE 06/05/2014.